Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-24

Clinical Trial Update: Faecal Microbiota Transplantation in Irritable Bowel Syndrome [NA]

View source ↗

Summary

A completed clinical trial investigated fecal microbiota transplantation as a treatment for irritable bowel syndrome, including IBS with diarrhea and IBS with m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Thomayer University Hospital | Conditions: Irritable Bowel Syndrome With Diarrhea, Irritable Bowel Syndrome Mixed | NA | Status: COMPLETED